Simplex Trading’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $319K | Buy |
11,800
+7,500
| +174% | +$252K | ﹤0.01% | 3762 |
|
|
2025
Q4 | $184K | Buy |
4,300
+2,400
| +126% | +$90.5K | ﹤0.01% | 4313 |
|
|
2025
Q3 | $53K | Buy |
1,900
+900
| +90% | +$26.9K | ﹤0.01% | 6399 |
|
|
2025
Q2 | $18K | Sell |
1,000
-2,700
| -73% | -$51.2K | ﹤0.01% | 6869 |
|
|
2025
Q1 | $66K | Sell |
3,700
-4,100
| -53% | -$83.2K | ﹤0.01% | 5500 |
|
|
2024
Q4 | $131K | Sell |
7,800
-11,900
| -60% | -$228K | ﹤0.01% | 4930 |
|
|
2024
Q3 | $318K | Sell |
19,700
-13,400
| -40% | -$158K | ﹤0.01% | 4067 |
|
|
2024
Q2 | $272K | Buy |
33,100
+30,700
| +1,279% | +$321K | ﹤0.01% | 4335 |
|
|
2024
Q1 | $35K | Sell |
2,400
-10,180
| -81% | -$137K | ﹤0.01% | 6614 |
|
|
2023
Q4 | $182K | Buy |
12,580
+2,110
| +20% | +$21.6K | ﹤0.01% | 4772 |
|
|
2023
Q3 | $113K | Sell |
10,470
-2,390
| -19% | -$28.8K | ﹤0.01% | 4968 |
|
|
2023
Q2 | $165K | Buy |
12,860
+2,380
| +23% | +$32.2K | ﹤0.01% | 4524 |
|
|
2023
Q1 | $138K | Sell |
10,480
-1,420
| -12% | -$22.6K | ﹤0.01% | 4780 |
|
|
2022
Q4 | $178K | Buy |
11,900
+7,120
| +149% | +$65.3K | ﹤0.01% | 4359 |
|
|
2022
Q3 | $56K | Sell |
4,780
-2,920
| -38% | -$39.5K | ﹤0.01% | 6287 |
|
|
2022
Q2 | $87K | Buy |
7,700
+2,960
| +62% | +$59.4K | ﹤0.01% | 5761 |
|
|
2022
Q1 | $141K | Sell |
4,740
-530
| -10% | -$14.3K | ﹤0.01% | 5672 |
|
|
2021
Q4 | $139K | Sell |
5,270
-2,980
| -36% | -$89.9K | ﹤0.01% | 5718 |
|
|
2021
Q3 | $371K | Buy |
8,250
+80
| +1% | +$3.15K | ﹤0.01% | 4558 |
|
|
2021
Q2 | $354K | Buy |
8,170
+8,092
| +10,374% | +$306K | ﹤0.01% | 4704 |
|
|
2021
Q1 | $267K | Buy |
78
+26
| +50% | +$1.03K | ﹤0.01% | 4289 |
|
|
2020
Q4 | $180K | Buy |
52
+39
| +300% | +$1.13K | ﹤0.01% | 4756 |
|
|
2020
Q3 | $30K | Buy |
13
+12
| +1,200% | +$295 | ﹤0.01% | 6073 |
|
|
2020
Q2 | $1K | Sell |
1
-4
| -80% | -$72 | ﹤0.01% | 7399 |
|
|
2020
Q1 | $7K | Sell |
5
-1
| -17% | -$21 | ﹤0.01% | 6688 |
|
|
2019
Q4 | $12K | Hold |
6
| – | – | ﹤0.01% | 6295 |
|
|
2019
Q3 | $11K | Buy |
6
+3
| +100% | +$62 | ﹤0.01% | 6203 |
|
|
2019
Q2 | $8K | Sell |
3
-44
| -94% | -$993 | ﹤0.01% | 6237 |
|
|
2019
Q1 | $120K | Buy |
47
+45
| +2,250% | +$1.03K | ﹤0.01% | 4150 |
|
|
2018
Q4 | $5K | Sell |
2
-1
| -33% | -$28 | ﹤0.01% | 6234 |
|
|
2018
Q3 | $10K | Sell |
3
-5
| -63% | -$150 | ﹤0.01% | 6420 |
|
|
2018
Q2 | $22K | Sell |
8
-115
| -93% | -$4.09K | ﹤0.01% | 5800 |
|
|
2018
Q1 | $59K | Buy |
123
+119
| +2,975% | +$4.76K | ﹤0.01% | 2279 |
|
|
2017
Q4 | $4K | Buy |
+4
| New | +$152 | ﹤0.01% | 4733 |
|
|
2017
Q3 | – | Sell |
-4
| Closed | -$1K | – | 6510 |
|
|
2017
Q2 | $1K | Sell |
4
-26
| -87% | -$712 | ﹤0.01% | 5704 |
|
|
2017
Q1 | $18K | Buy |
+30
| New | +$764 | ﹤0.01% | 3362 |
|
|
2016
Q4 | – | Sell |
-28
| Closed | -$5K | – | 6408 |
|
|
2016
Q3 | $5K | Buy |
+28
| New | +$803 | ﹤0.01% | 4305 |
|
|
2016
Q2 | – | Sell |
-5
| Closed | -$2K | – | 6357 |
|
|
2016
Q1 | $2K | Buy |
+5
| New | +$123 | ﹤0.01% | 4789 |
|
Other funds holding RIGL
AC
VCM
Simplex Trading's RIGL Position: Q4 2025 in Review
Simplex Trading sold out of Rigel Pharmaceuticals (RIGL) in Q4 2025, closing a stake of 1,305 shares — an estimated $49.2K sold.
Simplex Trading first reported a position in RIGL in Q4 2014 and held it in 26 quarters. The position peaked at $323K in Q1 2021. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.
- Simplex Trading reported no remaining Rigel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
- Simplex Trading sold 1,305 Rigel Pharmaceuticals shares in Q4 2025, an estimated $49.2K.
- Simplex Trading first reported a position in Rigel Pharmaceuticals in Q4 2014 and held it in 26 quarters.
- Simplex Trading's Rigel Pharmaceuticals position peaked at $323K in Q1 2021.
- 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.
Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.